The group that received this treatment showed a favorable trend in median survival (16.6 vs. 10.9 months); however, it was not statistically significant ( P = 0.755).
← all excerpts
Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis.
1
—
—